Close Menu

NEW YORK – Prenatal diagnostics firm Sera Prognostics announced Wednesday that it has raised $36 million in Series D financing.

The funding round was led by Blue Ox Healthcare Partners, an investment firm specializing in healthcare companies targeting individuality and value-based care, along with two other unnamed strategic healthcare companies. Existing investors that participated in the round include Domain Associates, InterWest Partners, Laboratory Corporation of America Holdings, Catalyst Health Ventures, and Chione.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.